Mark Suter
About
Mark Suter is a scholar working on Immunology, Epidemiology and Molecular Biology.
According to data from OpenAlex, Mark Suter has authored 90 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Immunology, 26 papers in Epidemiology and 23 papers in Molecular Biology. Recurrent topics in Mark Suter's work include Immunotherapy and Immune Responses (28 papers), Herpesvirus Infections and Treatments (22 papers) and Monoclonal and Polyclonal Antibodies Research (20 papers). Mark Suter is often cited by papers focused on Immunotherapy and Immune Responses (28 papers), Herpesvirus Infections and Treatments (22 papers) and Monoclonal and Polyclonal Antibodies Research (20 papers). Mark Suter collaborates with scholars based in Switzerland, United States and Australia. Mark Suter's co-authors include Hubertus Hochrein, Reto Crameri, Adrian F. Ochsenbein, Hans Hengartner, Thomas Fehr, Rolf M. Zinkernagel, Frank Brombacher, Meredith O’Keeffe, Ken Shortman and Nadine Fernandez and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.
In The Last Decade
Mark Suter
88 papers receiving 6.3k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Mark Suter Switzerland | 36 | 3.9k | 1.5k | 1.3k | 769 | 630 | 90 | 6.6k | ||
| Jeffrey A. Frelinger United States | 49 | 4.6k 1.2× | 2.1k 1.4× | 1.2k 1.0× | 816 1.1× | 951 1.5× | 214 | 8.0k | ||
| Luisa Martı́nez-Pomares United Kingdom | 48 | 4.5k 1.1× | 2.7k 1.8× | 1.3k 1.1× | 474 0.6× | 697 1.1× | 88 | 8.8k | ||
| Nicole Baumgarth United States | 50 | 5.9k 1.5× | 1.4k 0.9× | 1.6k 1.3× | 721 0.9× | 427 0.7× | 115 | 8.4k | ||
| R M Steinman United States | 36 | 9.1k 2.3× | 2.2k 1.5× | 783 0.6× | 864 1.1× | 1.4k 2.2× | 46 | 10.9k | ||
| Alana Althage United States | 33 | 4.3k 1.1× | 1.4k 1.0× | 1.6k 1.3× | 425 0.6× | 790 1.3× | 48 | 7.3k | ||
| Jeff Alexander United States | 42 | 3.6k 0.9× | 1.7k 1.1× | 1.2k 1.0× | 668 0.9× | 492 0.8× | 89 | 5.5k | ||
| John W. Lowenthal Australia | 41 | 3.9k 1.0× | 1.3k 0.9× | 1.0k 0.8× | 509 0.7× | 758 1.2× | 90 | 6.3k | ||
| Robert G. Urban United States | 22 | 5.1k 1.3× | 2.0k 1.4× | 855 0.7× | 1.4k 1.8× | 391 0.6× | 33 | 7.0k | ||
| Gregg J. Silverman United States | 51 | 6.5k 1.6× | 2.9k 1.9× | 1.1k 0.9× | 2.4k 3.2× | 592 0.9× | 191 | 10.9k | ||
| Stanley F. Wolf United States | 27 | 3.3k 0.8× | 1.4k 0.9× | 711 0.6× | 199 0.3× | 904 1.4× | 51 | 5.3k |
Countries citing papers authored by Mark Suter
Since
Specialization
Citations
This map shows the geographic impact of Mark Suter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Suter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Suter more than expected).
Fields of papers citing papers by Mark Suter
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Mark Suter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Suter. The network helps show where Mark Suter may publish in the future.
Co-authorship network of co-authors of Mark Suter
This figure shows the co-authorship network connecting the top 25 collaborators of Mark Suter. A scholar is included among the top collaborators of Mark Suter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Suter. Mark Suter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Hinterberger, Maria, Barbara Bathke, Sonia Wennier, et al.. (2021). Intratumoral virotherapy with 4-1BBL armed modified vaccinia Ankara eradicates solid tumors and promotes protective immune memory. Journal for ImmunoTherapy of Cancer. 9(2). e001586–e001586.
2.
Suter, Mark, Elisabeth M. Schraner, Bruno M. Humbel, et al.. (2017). Transfer of Anti-Rotavirus Antibodies during Pregnancy and in Milk Following Maternal Vaccination with a Herpes Simplex Virus Type-1 Amplicon Vector. International Journal of Molecular Sciences. 18(2). 431–431.
3.
Lauterbach, Henning, Barbara Bathke, Kay Brinkmann, et al.. (2013). Genetic Adjuvantation of Recombinant MVA with CD40L Potentiates CD8 T Cell Mediated Immunity. Frontiers in Immunology. 4. 251–251.
4.
Oldenburg, Marina, Anne Krüger, Ruth Ferstl, et al.. (2012). TLR13 Recognizes Bacterial 23 S rRNA Devoid of Erythromycin Resistance–Forming Modification. Science. 337(6098). 1111–1115.
5.
Hässig, M., et al.. (2012). Einfluss kolostraler Antikörper auf die postvakzinale humorale Immunantwort bei neonatalen Kälbern. Schweizer Archiv für Tierheilkunde. 154(4). 141–147.
6.
Pinschewer, Daniel D., Lukas Flatz, Ralf Steinborn, et al.. (2010). Innate and adaptive immune control of genetically engineered live-attenuated arenavirus vaccine prototypes. International Immunology. 22(9). 749–756.
7.
Brinkmann, Kay, Marc Schweneker, Robin Steigerwald, et al.. (2010). Immediate-Early Expression of a Recombinant Antigen by Modified Vaccinia Virus Ankara Breaks the Immunodominance of Strong Vector-Specific B8R Antigen in Acute and Memory CD8 T-Cell Responses. Journal of Virology. 84(17). 8743–8752.
8.
Suter, Mark & H. Fey. (2010). Isolation and Characterisation of Equine IgE. Zentralblatt für Veterinärmedizin Reihe B. 28(5). 414–420.
9.
Suter, Mark, et al.. (2009). Modified vaccinia Ankara strains with identical coding sequences actually represent complex mixtures of viruses that determine the biological properties of each strain. Vaccine. 27(52). 7442–7450.
10.
Hausmann, Jürgen, Henning Lauterbach, Michaela Schmidt, et al.. (2008). Survival of lethal poxvirus infection in mice depends on TLR9, and therapeutic vaccination provides protection. Journal of Clinical Investigation. 118(5). 1776–1784.
11.
Schmidt, Michaela, Burkhard Linke, Lutz Krause, et al.. (2007). Genomic sequence of chorioallantois vaccinia virus Ankara, the ancestor of modified vaccinia virus Ankara. Journal of General Virology. 88(12). 3249–3259.
12.
Mueller, Scott N., Claerwen M. Jones, Angus T. Stock, et al.. (2006). CD4+ T Cells Can Protect APC from CTL-Mediated Elimination. The Journal of Immunology. 176(12). 7379–7384.
13.
Franchini, Marco, Sabine Vollstedt, Mathias Ackermann, et al.. (2004). Dendritic Cells from Mice Neonatally Vaccinated with Modified Vaccinia Virus Ankara Transfer Resistance against Herpes Simplex Virus Type I to Naive One-Week-Old Mice. The Journal of Immunology. 172(10). 6304–6312.
14.
Vollstedt, Sabine, Marco Franchini, Hans Peter Hefti, et al.. (2003). Flt3 Ligand–treated Neonatal Mice Have Increased Innate Immunity Against Intracellular Pathogens and Efficiently Control Virus Infections. The Journal of Experimental Medicine. 197(5). 575–584.
15.
Grob, Philipp, et al.. (1999). Role of the Individual Interferon Systems and Specific Immunity in Mice in Controlling Systemic Dissemination of Attenuated Pseudorabies Virus Infection. Journal of Virology. 73(6). 4748–4754.
16.
Ackermann, Mathias, et al.. (1997). Immortalized Cell Lines with Dendritic Morphology Derived from Mice Lacking Both Type I and Type II Interferon Receptors Present MHC II Restricted Antigen to T Cells and Induce Mixed Leukocyte Reactions. Advances in experimental medicine and biology. 417. 425–432.
17.
Lang, Aloïs B., et al.. (1994). Human monoclonal or polyclonal antibodies recognize predominantly discontinuous epitopes on bee venom phospholipase A2. Journal of Allergy and Clinical Immunology. 94(1). 61–70.
18.
Crameri, Reto & Mark Suter. (1993). Display of biologically active proteins on the surface of filamentous phages: a cDNA cloning system for selection of functional gene products linked to the genetic information responsible for their production. Gene. 137(1). 69–75.
19.
DiPietro, Luisa A., et al.. (1992). Limited repertoire of utilized VH gene segments in a VHa3-allotype-suppressed rabbit. International Immunology. 4(5). 555–561.
20.
Suter, Mark, Robert S. Becker, & K L Knight. (1990). Rearrangement of VHa1-encoding Ig gene segment to the a2 chromosome in an a1/a2 heterozygous rabbit. Evidence for trans recombination.. The Journal of Immunology. 144(5). 1997–2000.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Jeffrey A. Frelinger Breakdown of academic impact, for papers by Luisa Martı́nez-Pomares Breakdown of academic impact, for papers by Nicole Baumgarth Breakdown of academic impact, for papers by R M Steinman Breakdown of academic impact, for papers by Alana Althage Breakdown of academic impact, for papers by Jeff Alexander Breakdown of academic impact, for papers by John W. Lowenthal Breakdown of academic impact, for papers by Robert G. Urban Breakdown of academic impact, for papers by Gregg J. Silverman Breakdown of academic impact, for papers by Stanley F. Wolf